Literature DB >> 27399234

A Review of the Medicinal Uses and Pharmacology of Ashitaba.

Lindsay K Caesar1, Nadja B Cech1.   

Abstract

Angelica keiskei Koidzumi, or ashitaba, is a popular botanical medicine in Japan containing diverse bioactive components including prenylated chalcones, linear and angular coumarins, and flavanones. This review provides an overview of the current knowledge of ashitaba metabolites and their biological activities to prioritize future studies. Ashitaba is purported to possess cytotoxic, antidiabetic, antioxidative, anti-inflammatory, antihypertensive, and antimicrobial properties. Although many in vitro studies have been conducted on ashitaba's chemical constituents, the in vivo efficacy and clinical relevance of this plant has yet to be confirmed for most of these activities. Here we describe the chemical composition of ashitaba and present the pharmacological effects of this botanical as supported by the current literature. The experimental results demonstrate promise for the medical use of ashitaba, but considerable work needs to be done to understand the mechanisms of action of its metabolites. Additionally, in vivo and clinical trials as well as additional studies on less abundant bioactive compounds are warranted. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27399234     DOI: 10.1055/s-0042-110496

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

1.  Integration of Biochemometrics and Molecular Networking to Identify Antimicrobials in Angelica keiskei.

Authors:  Lindsay K Caesar; Joshua J Kellogg; Olav M Kvalheim; Richard A Cech; Nadja B Cech
Journal:  Planta Med       Date:  2018-03-23       Impact factor: 3.352

2.  Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins.

Authors:  Melina Mottin; Lindsay K Caesar; David Brodsky; Nathalya C M R Mesquita; Ketllyn Zagato de Oliveira; Gabriela Dias Noske; Bruna K P Sousa; Paulo R P S Ramos; Hannah Jarmer; Bonnie Loh; Kimberley M Zorn; Daniel H Foil; Pedro M Torres; Rafael V C Guido; Glaucius Oliva; Frank Scholle; Sean Ekins; Nadja B Cech; Carolina H Andrade; Scott M Laster
Journal:  Bioorg Chem       Date:  2022-01-31       Impact factor: 5.307

3.  FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.

Authors:  Yuanyuan Shi; Xuejiao Liu; Mangaladoss Fredimoses; Mengqiu Song; Hanyong Chen; Kangdong Liu; Mee-Hyun Lee; Zigang Dong
Journal:  J Cell Biochem       Date:  2017-10-27       Impact factor: 4.429

4.  The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis.

Authors:  Sri Agung Fitri Kusuma; Yoppi Iskandar; Mutiara Ayu Dewanti
Journal:  J Adv Pharm Technol Res       Date:  2018 Jan-Mar

5.  Characterizing Tyrosinase Modulators from the Roots of Angelica keiskei Using Tyrosinase Inhibition Assay and UPLC-MS/MS as the Combinatorial Novel Approach.

Authors:  Jia-Hao Lee; Hui-Ching Mei; I-Chih Kuo; Tzong-Huei Lee; Yu-Hsin Chen; Ching-Kuo Lee
Journal:  Molecules       Date:  2019-09-10       Impact factor: 4.411

6.  Effects of Microbial Transformation on the Biological Activities of Prenylated Chalcones from Angelica keiskei.

Authors:  Yina Xiao; Ik-Soo Lee
Journal:  Foods       Date:  2022-02-14

7.  In vitro embryotoxicity and mode of antibacterial mechanistic study of gold and copper nanoparticles synthesized from Angelica keiskei (Miq.) Koidz. leaves extract.

Authors:  Chandran Krishnaraj; Glenn M Young; Soon-Il Yun
Journal:  Saudi J Biol Sci       Date:  2021-12-17       Impact factor: 4.052

8.  A Chalcone from Ashitaba (Angelica keiskei) Stimulates Myoblast Differentiation and Inhibits Dexamethasone-Induced Muscle Atrophy.

Authors:  Minson Kweon; Hyejin Lee; Cheol Park; Yung Hyun Choi; Jae-Ha Ryu
Journal:  Nutrients       Date:  2019-10-10       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.